• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Sparta Science Raises a New Round of Funding to Help Organizations Optimize Movement Health Outcomes at Scale

Share:

April 3, 2023

Sparta Science, a leader in Movement Health Intelligence, has secured additional funding led by Spring Lake Equity Partners. The funding round, which also included General Purpose Venture Capital and existing investors, raised $34 million, which will be used to accelerate product innovation and hiring. Sparta Science’s platform is used by over 180 sports, military, and healthcare organizations to understand and optimize human movement. The company provides enterprises with a holistic Movement Health platform by leveraging high-quality movement assessments, expansive integrations, and a robust biomarker data platform. Organizations that use Sparta Science’s platform gain the visibility and insights to deliver higher-quality care.

Sparta Science, the enterprise leader in Movement Health Intelligence, announced an additional round of funding led by Spring Lake Equity Partners.

The funding round also included General Purpose Venture Capital (GPVC) and existing investors, bringing the company’s total funding to $34 million.

The new capital will be used to accelerate product innovation and hiring, building upon recent growth within enterprise-scale organizations. Last year, Sparta Science saw a 30 percent increase in sales; their platform is now used by over 180 sports, military, and healthcare organizations to understand and optimize human movement.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

“Our investors understand the role of movement in the bigger picture of health and well-being and the value an AI platform can deliver to this space,” said Phil Wagner, Founder and CEO of Sparta Science. “We share the vision of a more data-rich future for organizations, delivering better movement health insights to optimize decision-making for clinicians, users, and businesses.”

Sparta Science provides enterprises with a holistic Movement Health platform by leveraging high-quality movement assessments, expansive integrations, and a robust biomarker data platform. With it, organizations gain the visibility and insights to deliver higher-quality care.

“More and more health measurement devices are accessible to consumers and providers, yet movement-related conditions are rising steadily across all populations,” said Dante Balestracci, Principal at Spring Lake. “Sparta Science’s Big Data approach to Movement Health enables organizations to standardize assessments, benchmark users, and promote data-driven decision-making across the organization. We are excited to support the Sparta Science team so more organizations can improve health outcomes through a centralized, intelligent platform.”

“We are impressed with the team at Sparta Science and their unique blend of subject matter expertise in healthcare and technical domains,” said Dan Kistler, Managing Director at GPVC. “In a digital health space flooded with legacy solutions, we appreciate the pragmatic yet innovative approach formed by a team that has felt the real-world pains that their solution addresses.”

Source: BioSpace

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • 908 Devices Acquires TRACE Analytics, Enabling On-Line Bioanalytics908 Devices Acquires TRACE Analytics, Enabling On-Line Bioanalytics
  • Pharmaceutical Logistics Market Analysis, COVID-19 Impact,Outlook, Opportunities, Size, Share Forecast and Supply Demand 2021-2027Pharmaceutical Logistics Market Analysis, COVID-19 Impact,Outlook, Opportunities, Size, Share Forecast and Supply Demand 2021-2027
  • Bruker Completes Acquisition of Majority Interest in Infectious Disease Molecular Diagnostics Company Hain Lifescience GmbHBruker Completes Acquisition of Majority Interest in Infectious Disease Molecular Diagnostics Company Hain Lifescience GmbH
  • Takeda’s Shire Takeover Seen Facing EU Scrutiny of Drug ResearchTakeda’s Shire Takeover Seen Facing EU Scrutiny of Drug Research
  • Philips, Spencer Health Launches In-Home Medication Adherence & Telehealth Platform in EuropePhilips, Spencer Health Launches In-Home Medication Adherence & Telehealth Platform in Europe
  • Massive Growth: E Pharma Market Report to Observer Significant DevelopmentMassive Growth: E Pharma Market Report to Observer Significant Development
  • Rafina Innovations Inc. Acquires C-PHARM Ltd PharmaceuticalRafina Innovations Inc. Acquires C-PHARM Ltd Pharmaceutical
  • Erbi Biosystems Raises $3.8M to Expand Their Platform of Microfluidic Bioprocess and Bioreactor Equipment, Which Enables Ultra-High Cell Density and Continuous ProcessingErbi Biosystems Raises $3.8M to Expand Their Platform of Microfluidic Bioprocess and Bioreactor Equipment, Which Enables Ultra-High Cell Density and Continuous Processing

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications